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Abstract
The effects of immune cells, in particular macrophages, on the behaviour of mesen-
chymal stromal cells (MSCs) have recently gained much attention for MSCs‐based
tissue‐engineered constructs. This study aimed to evaluate the effect of
monocytes/macrophages on the osteogenic differentiation of adipose‐derived mes-
enchymal stromal cells (ADMSCs) in three‐dimensional (3D) cocultures. For this, we
cocultured THP‐1 monocytes, M1 macrophages, or M2 macrophages with ADMSCs
on 3D poly(lactic‐co‐glycolic) acid (PLGA)/polycaprolactone (PCL) scaffolds using
osteogenic medium for up to 42 days. We found that osteogenic differentiation of
ADMSCs was inhibited by monocytes and both macrophage subtypes in 3D scaffolds.
Furthermore, coculture of monocytes/macrophages with ADMSCs resulted in down-
regulated secretion of oncostatin M (OSM) and bone morphogenetic protein 2 (BMP‐
2) and inhibited expression of osteogenic markers alkaline phosphatase (ALP), bone
sialoprotein (BSP), and runt‐related transcription factor 2 (RUNX2). Compared with
both macrophage subtypes, monocytes inhibited osteogenic differentiation of
ADMSCs more significantly. These data suggest that the mutual interactions between
monocytes/macrophages and ADMSCs negatively affect MSC osteogenic differenti-
ation and thus possibly bone healing capacity, which highlights the importance of
the micro‐environment in influencing cell‐based constructs to treat bone defects
and the potential to improve their performance by resolving the inflammation ahead
of treatment.
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1 | INTRODUCTION
Inflammation is the first stage of bone healing after bone injury. The
state of inflammation has been indicated to affect the delicate balance
between bone formation and bone degradation (Loi et al., 2016).
Monocytes and macrophages are vital modulators of inflammation
(Nich et al., 2013) and display the transition of different phases in tissue
regeneration (Wynn & Vannella, 2016). The crosstalk between
monocytes/macrophages and cells involved in tissue regeneration,
such as mesenchymal stromal cells (MSCs), is critical for normal tissue
formation and healing (Guihard et al., 2012; Guihard et al., 2015; Vi
et al., 2015). Upon injury, monocytes are recruited from the peripheral
circulation and enter injured sites, where they differentiate into macro-
phages (Rickard & Young, 2009). The recruited macrophages respond
to signals from the micro‐environment in which they reside by acquir-
ing different phenotypes (Wynn & Vannella, 2016). Thesemacrophages
are generally classified as either classically activated macrophages (M1)
or alternatively activatedmacrophages (M2;Murray et al., 2014; Spiller,
Freytes, & Vunjak‐Novakovic, 2015). Based on current knowledge, M1
macrophages are responsible for angiogenesis and the removal of
necrotic tissue at an early stage, whereas M2 macrophages are respon-
sible for immune regulation, matrix deposition, and tissue remodelling
at a later stage (C. Chen, Uludag, Wang, Rezansoff, & Jiang, 2012).
Recent studies reported a switch of macrophage subtypes from pro‐
inflammatoryM1macrophages to pro‐wound healingM2macrophages
during the bone healing process (Tasso et al., 2013; Wu et al., 2015),
demonstrating the crucial role of monocytes and different macrophage
subtypes in bone healing.
To further elucidate the interaction of different macrophage sub-
types with bone forming cells, such as MSCs, in vitro, our group has
previously established a two‐dimensional (2D) coculture system where
different types of macrophages were cocultured with adipose‐derived
mesenchymal stromal cells (ADMSCs; Zhang et al., 2017). This study
demonstrated that M2 macrophages, rather than M1 macrophages,
can promote the osteogenic differentiation of ADMSCs. Although cul-
turing cells on 2D substrates has been considered a standard tech-
nique for in vitro cell culture, it is recognized that cells more closely
mimic native tissues when cultured in a three‐dimensional (3D) envi-
ronment. In 3D cell cultures, cells adhere to each other via the extra-
cellular matrix (ECM) and form specific cell–cell contacts, which
differentially regulate cell growth, migration, and differentiation (Lee,
Cuddihy, & Kotov, 2008). This is supported by findings of significant
divergence of cell–cell interactions for cells in 2D and 3D culture sys-
tems in previous studies (D. Y. Chen et al., 2013; Valles et al., 2015).
Furthermore, 3D scaffolds are widely used for tissue engineering
applications. The most widely used materials for tissue engineering
are polymeric materials because they are easily processable, biocom-
patible, and biodegradable and can be modified with desired proper-
ties (e.g., dimensions and porosity; Ceccarelli et al., 2013). In recent
years, polymers have been processed via electrospinning to fabricate
nanofibres for different applications in skin (Duan et al., 2006), blood
vessel (Vaz, van Tuijl, Bouten, & Baaijens, 2005), and bone tissue
regeneration (Zhang et al., 2008). Electrospun fibres represent
morphological similarity to natural ECM, which makes them attractive
for cells to proliferate and function effectively (Yang, Yang, Wang,
Both, & Jansen, 2013). The interfibre pores that are obtained within
electrospun fibre meshes render such scaffolds highly interactive with
its surrounding tissue due to the high specific surface area (Holzwarth
& Ma, 2011). To make full use of the functionality of multiple polymer
types in one electrospun mesh, the blend electrospun method, which
allows the simultaneous combination of multiple polymers during the
electrospinning process, has gained much attention (Hiep & Lee,
2010). An attractive polymer combination for electrospun meshes
includes poly(lactic‐co‐glycolic) acid (PLGA), which is suitable for cell
adhesion and proliferation due to its hydrophilic properties, and
polycaprolactone (PCL), which is a flexible biopolymer that can be
used to overcome the brittle and low elongation properties of PLGA
(Kim & Cho, 2009).
For initial biological evaluation using cell culture models, culture
conditions for cocultures require special attention regarding medium
composition and nutritional supplement. Although standardized culture
conditions have been established for most monocultures (American
Type Culture Collection, 2018), coculture models require a justified
choice for a specific medium. Mostly, this choice is based on the
research question that favours behavioural analysis of the predominant
cell type within the coculture, for example, vascular cells for angiogenic
behaviour (Hofmann et al., 2008; Levenberg et al., 2005) and MSCs for
osteogenic differentiation (Ma et al., 2011; Ma et al., 2014). As a nutri-
tional supplement, fetal bovine serum (FBS) has been commonly used
for multiple cell types. However, the major drawback of this supple-
ment is the possibility to trigger an immunological response due to
the presence of xenogeneic antigens (Bieback et al., 2009). Conse-
quently, it has been postulated that the use of FBS should be avoided
for human cell cultures (Ma et al., 2015). In contrast, platelet lysate
(PL) is of human origin, can be applied as an autologous nutritional sup-
plement for primary cells, and contains various growth factors and cyto-
kines, including platelet‐derived growth factor (PDGF), basic fibroblast
growth factor (bFGF), insulin‐like growth factor 1 (IGF‐1), and
transforming growth factor β (TGF‐β; Doucet et al., 2005). A vast amount
of scientific literature has reported on the capacity of PL to promote the
proliferation and differentiation of MSCs into different lineages (Altaie,
Owston, & Jones, 2016; Fekete et al., 2012; Shanskii et al., 2013). In
particular, PL has been demonstrated to be an optimal serum supplement
to culture ADMSCs for bone regeneration (Hayrapetyan, Bongio,
Leeuwenburgh, Jansen, & van den Beucken, 2016; Ma et al., 2015).
Furthermore, PL was also used in tissue‐engineered scaffolds to benefit
the innate immune response for superior tissue regeneration. It was
found that PL can induce an anti‐inflammatory response of monocytes/
macrophages (Linke et al., 2017). These findings suggest the potential
of using PL to culture human cells for the clinical usage.
The objective of this study was to evaluate the effect of mono-
cytes and macrophage subtypes on osteogenic differentiation of
ADMSCs cultured on 3D PLGA/PCL scaffolds using a direct coculture
model. We hypothesized that monocytes and macrophage subtypes
would differentially affect the osteogenic differentiation of ADMSCs
compared with ADMSCs monocultures on PLGA/PCL scaffolds.
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2 | MATERIALS AND METHODS
2.1 | Cells and reagents
ADMSCs were obtained from human subcutaneous adipose tissue,
and human monocytic THP‐1 cells were obtained from the American
Type Culture Collection (Manassas, VA, USA). Alpha Minimum
Essential Medium (αMEM), RPMI‐1640 medium, and penicillin–
streptomycin were purchased from Gibco (GrandIsland, USA). FBS,
bovine serum albumin (BSA), trypsin, bFGF, phorbol‐12‐myristate‐
13‐acetate (PMA), lipopolysaccharide (LPS), interferon gamma (IFN‐γ),
interleukin 4 (IL‐4), IL‐13, β‐glycerol 2‐phosphate disodium salt hydrate
(β‐glycerophosphate), dexamethasone, and ascorbic acid were pur-
chased from Sigma‐Aldrich (St. Louis, USA). Heparin was obtained from
LEO Pharma A/S (Ballerup, Denmark). Collagenase A was purchased
from Roche Diagnostics (Mannheim, Germany). Tumour necrosis factor
alpha (TNF‐α) and TGF‐β enzyme‐linked immunosorbent assay (ELISA)
kits were purchased from eBioscience (San Diego, USA). Oncostatin M
(OSM) and bonemorphogenetic protein 2 (BMP‐2) ELISA kits were pur-
chased from Sigma‐Aldrich (St. Louis, USA). Monoclonal anti‐human
CCR7 antibody was purchased from Abcam (Cambridge, UK), mouse
purified anti‐human CD36 was obtained from BioLegend (San Diego,
USA), and mouse anti‐human CD68 was purchased from Dako
(Heverlee, Belgium). All secondary antibodies and 4′,6‐diamidino‐2‐
phenylindole (DAPI) were purchased from Invitrogen (Waltham, USA).
All cell culture flasks, dishes, and plates were purchased from Greiner
Bio‐One (Frickenhausen, Germany).
2.2 | Isolation, preculture, and characterization of
ADMSCs
ADMSCs isolation was performed as described previously (Varma
et al., 2007). Briefly, human subcutaneous adipose tissue was obtained
from the Department of Plastic Surgery (Radboudumc, Nijmegen, the
Netherlands) after ethical approval (CMO Radboudumc; dossier#
2017‐3252) and written informed consent. Resected fat tissue was
minced using surgical scalpels and scissors and washed with
phosphate‐buffered saline (PBS) for three times. The tissue was
digested with 0.1% collagenase A in PBS containing 1% BSA at 37°C
for 60 min with intermittent shaking. The digested tissue was centri-
fuged for 10 min at 600 g, and the cell pellet was resuspended in
5 ml of PBS/1% BSA and filtered with a 100‐μm nylon mesh (Roche
Diagnostics). Cells were then subjected to a Ficoll density centrifuga-
tion (Lymphoprep™, 1,000 g, 20 min; Axis‐Shield, Oslo, Norway) step
to remove erythrocytes and were seeded at a density of 1 × 105
cells/cm2 in αMEM containing 10% FBS, 100‐U/ml penicillin,
100‐μg/ml streptomycin, and 1‐ng/ml bFGF, and cultured in a humid-
ified atmosphere of 5% CO2 at 37°C. Medium was changed twice a
week. When near confluent (90%), cells were detached with 0.5‐mM
EDTA/0.05% trypsin and passaged or frozen in 1 × 106 cells/ml ali-
quots in liquid nitrogen. ADMSCs from passages 3 to 5 were used in
further experiments.
The expression of surface antigens was evaluated by incubating
ADMSCs at 4°C for 1 hr with the respective antibodies in 100‐μl FACS
buffer (1‐mM EDTA in PBS with 0.5% BSA; Sigma). The following anti-
bodies were used for evaluation: FITC mouse anti‐human CD45, APC
mouse anti‐human CD73, PerCP‐Cy 5.5 mouse anti‐human CD90,
and PE mouse anti‐human CD105 (all from BD Pharmingen,
Piscataway, USA). Cells without antibodies were used as negative con-
trols. Labelled cells were washed twice in 1‐ml FACS buffer and
analysed with the FACSAria II flow cytometer (BD biosciences, San
Jose, CA, USA). Data were processed using Flowing software 2.5.1
(University of Turku, Turku, Finland), and the percentage population
of each antibody that stained positively for the respective markers
was compared with negative controls.
2.3 | Culture, activation, and polarization of THP‐1
cells
Human monocytic THP‐1 cells were cultured in RPMI‐1640 medium sup-
plemented with 10% FBS, 100‐U/ml penicillin, and 100‐μg/ml streptomy-
cin. THP‐1 cells were differentiated into macrophages using a previously
published protocol (Freytes, Kang, Marcos‐Campos, & Vunjak‐Novakovic,
2013). Briefly, 5 × 106 cells were added into 100‐mm culture dishes with
15‐ml culture medium plus 50‐ng/ml PMA for 48 hr to activate mono-
cytes into M0 macrophages. Then M0 macrophages were treated for
another 48 hr either with 20‐ng/ml IFN‐γ and 240‐ng/ml LPS to obtain
M1 macrophages, or with 20‐ng/ml IL‐4 and 20‐ng/ml IL‐13 to obtain
M2 macrophages. After the polarization, the supernatant was collected
for characterization, and the cells were washed twice with PBS. The cells
were then used for coculture with ADMSCs.
M1 and M2 phenotypes were characterized by measuring the con-
centration of TNF‐α and TGF‐β in collected supernatants from polar-
ized macrophages using the respective ELISA kits. ELISA kits were
used according to the manufacturer's instructions. M1 and M2 pheno-
types were further characterized by immunostaining for the M1 mac-
rophage marker CCR7 and M2 macrophage marker CD36 (Stewart,
Yang, Makowski, & Troester, 2012). The cells were fixed with 4% para-
formaldehyde for 15 min and then blocked with incubation buffer (1%
BSA in PBS) for 1 hr at room temperature. Samples were incubated
with the primary antibodies rabbit anti‐human CCR7 (1:500) and
mouse anti‐human CD36 (1:100) for 2 hr in incubation buffer. After
washing three times with PBS, the cells were incubated with the sec-
ondary antibodies donkey anti‐rabbit Alexa Fluor 568‐labelled IgG and
goat anti‐mouse Alexa Fluor 488‐labelled IgG (both 1:200) for 1 hr at
room temperature in the dark. After washing three times with PBS,
the cells were incubated with DAPI for 5 min. Immunofluorescence
images were acquired with a fluorescence microscope (Zeiss AxioCam
MRc5, Carl Zeiss Microimaging GmbH, Germany), and the relative
intensity of fluorescence was analysed using ImageJ (U.S. National
Institutes of Health, Bethesda, USA). The value of red (Alexa 568)
and green (Alexa 488) fluorescence of each sample was further nor-
malized for the value of blue fluorescence (DAPI), as described previ-
ously (Zhang et al., 2017).
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2.4 | Preparation of PL
PL was prepared as described previously (Prins et al., 2009). Briefly,
pooled platelet products containing approximately 1 × 109
thrombocytes/ml were purchased from the Sanquin Blood Bank (Nij-
megen, the Netherlands). The product was divided into 5‐ml aliquots
in 15‐ml tubes (Greiner Bio‐One), subjected to one freeze/thaw
(−80°C/37°C) cycle and stored at −80°C until use. Before adding to
the medium, PL was thawed and centrifuged at 2,000 g for 10 min to
remove remaining platelet fragments.
2.5 | Scaffolds preparation and cell loading
PLGA (Purasorb® PDLG 8531, Purac Biomaterials BV, Gorinchem, the
Netherlands) and PCL (LACTEL® Absorbable Polymers, DURECT Cor-
poration, Cupertino, CA, USA) were used in the electrospinning pro-
cess. Organic solvent 2,2,2‐trifluoroethanol (purity 99.8%) was
obtained from Acros (Geel, Belgium). The electrospinning solution
was prepared by dissolving PLGA/PCL (weight ratio 3:1) in 2,2,2‐
trifluoroethanol at a concentration of 0.12 g/ml.
The 3D scaffolds were fabricated using a so‐called wet‐
electrospinning technique in a commercially available electrospinning
set‐up (Esprayer ES‐2000S, Fuence, Tokyo, Japan). The optimal pro-
cessing parameters for stable formation of electrospun fibres were
selected based on an earlier publication (Yang et al., 2013). Briefly,
the prepared polymer solution was fed into a glass syringe and deliv-
ered to an 18G nozzle at a feeding rate of 50 μl/min. A high voltage
(20–25 kV) was applied at the nozzle to generate a stable polymer jet
by overcoming the surface tension of the polymer solution. A grounded
bath filled with 100% ethanol located 15 cm under the nozzle was used
to collect the fibres. To control the size of resulting fibre meshes, the
process was stopped every 15 min for fibre mesh collection. Subse-
quently, the wet‐electrospun scaffolds were washed thoroughly in
MilliQ and freeze‐dried (VirTis BenchTop Pro with Omnitronics Freeze
Dryer, SP Scientific, NY, USA) for 3 days. The obtained scaffold
displayed an uncompressed structure with an average fibre diameter
of 1.98 ± 0.51 μm and a porosity of 99% (Yang et al., 2013).
Disk‐shaped scaffolds with a diameter of 6 mm and a thickness of
about 2 mm were punched out using a biopsy punch (Kai medical, Gifu,
Japan) from each wet‐electrospun mesh and subsequently sterilized in
70% ethanol for 2 hr and soaked in proliferation medium overnight.
The experimental procedure of this study is schematically repre-
sented in Figure 1. To analyse the distinctive roles of monocytic
THP‐1 cells, M1 macrophages, and M2 macrophages on the osteo-
genic differentiation of ADMSCs, four experimental groups were used:
1. ADMSC (5 × 105 ADMSCs; monoculture control)
2. THP1‐ADMSC (5 × 105 ADMSCs with 5 × 105 THP‐1 cells)
3. M1‐ADMSC (5 × 105 ADMSCs with 5 × 105 M1 macrophages)
4. M2‐ADMSC (5 × 105 ADMSCs with 5 × 105 M2 macrophages)
The scaffolds were placed into 96‐well plates. The cells were
trypsinized and resuspended in proliferation medium, and 5 × 105 cells
in 25‐μl medium were seeded onto each scaffold. Scaffolds were
FIGURE 1 Schematic representation of the experimental design. ADMSCs: adipose‐derived mesenchymal stromal cells; ALP: alkaline
phosphatase; TNF‐α: tumour necrosis factor alpha; BMP‐2: bone morphogenetic protein 2; BSP: bone sialoprotein; COL1: collagen type 1;
DAPI: 4′,6‐diamidino‐2‐phenylindole; GAPDH: glyceraldehyde 3‐phosphate dehydrogenase; HE: haematoxylin and eosin; OSM: oncostatin M;
PCL: polycaprolactone; PLGA: poly(lactic‐co‐glycolic) acid; RT‐PCR: reverse transcription polymerase chain reaction; RUNX2: runt‐related
transcription factor 2; TGF‐β: transforming growth factor β [Colour figure can be viewed at wileyonlinelibrary.com]
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incubated for 3 hr for initial attachment, and then 300‐μl proliferation
medium was added; 24 hr later, the scaffolds were placed in 48‐well
suspension plates, and 1‐ml osteogenic medium (αMEM supplemented
with 5% PL, 10‐U/ml heparin, 1% penicillin–streptomycin antibiotic mix-
ture, 50‐μg/ml ascorbic acid, 10‐mM β‐glycerophosphate, and 10−8‐M
dexamethasone) was added. The cell–scaffold constructs were cultured
for 42 days, and the medium was refreshed thrice a week.
2.6 | Analyses
2.6.1 | Cell loading efficiency and DNA content
To evaluate the cell loading efficiency for each group, DNA content of
the loaded cells was measured after 24 hr of seeding. Scaffolds with
cells were also collected on Days 3, 7, 14, and 28 for DNA content
measurement (n = 3). Samples were washed twice with PBS, trans-
ferred to 1.5‐ml Eppendorf tubes, and digested with 0.1% collagenase
A in PBS and 1% BSA for 16 hr at 37°C with intermittent shaking. The
digested samples were centrifuged for 5 min at 2,000 g. The superna-
tant was aspirated, and 1 ml of MilliQ was added to each tube after
which repetitive freezing (−80°C) and thawing (room temperature)
cycles were performed; 5 × 105 ADMSCs with or without 5 × 105 of
another type of cells were suspended in 1 ml of MilliQ, which was
regarded as 100% control. DNA content was quantified using the
QuantiFluor dsDNA System (Promega Corporation, Madison, USA)
according to the manufacturer's instructions. A DNA standard curve
was used to quantify the amount of DNA in each sample, and the
results were measured using a multimode microplate reader (Synergy
HTX, Bio‐Tek Instruments, Vermont, USA) with an excitation wave-
length at 485/20 nm and an emission wavelength at 528/20 nm.
Loading efficiency in each group was calculated through division of
the result by the respective 100% control.
2.6.2 | ALP activity
Gross alkaline phosphatase (ALP) activity was measured using the same
samples as described for the DNA content measurement. For the assay,
80 μl of sample and 20 μl of buffer solution (0.5‐M AMP) were added
in 96‐well plates. Then 100 μl of substrate solution (5‐nM
p‐nitrophenylphosphate disodium salt; Sigma‐Aldrich, St. Louis, USA)
was added in all the wells, and the plates were incubated at 37°C for
1 hr. The reaction was stopped by adding 100 μl of stop solution (0.3‐
M NaOH; Sigma‐Aldrich, St. Louis, USA). For the standard curve, serial
dilutions of 4‐nitrophenol were added to a final amount of 0–25 nmol.
The absorbance of the samples was read using a multimode microplate
reader (Synergy HTX, Bio‐Tek Instruments, Vermont, USA) at 405 nm.
2.6.3 | Mineralization
Mineralization was measured using a calcium assay
(orthocresolphtalein complexone; Sigma). Samples were collected on
Days 14, 28, and 42. Scaffolds were washed twice with PBS, after
which 1 ml of 0.5‐N acetic acid (Sigma‐Aldrich, the Netherlands) was
added to each well (n = 3). The plate was incubated on a shaking table
overnight at room temperature. For the assay, 10 μl of sample or stan-
dard was pipetted in a 96‐well plate, followed by the addition of
300‐μl working solution. Working solution consisted of five portions
of 14.8‐M ethanolamine/boric acid buffer (pH = 11), five portions of
orthocresolphtalein complexone solution, two portions of 8‐
hydroxyquinoline, and 88 portions of MilliQ. For the standard curve,
serial dilutions of calcium stock (CaCl2) were prepared to final concen-
trations of 0–100 μg/ml. The plates were incubated at room temper-
ature for 5–10 min, and the absorbance was read using a multimode
microplate reader (Synergy HTX, Bio‐Tek Instruments, Vermont,
USA) at 570 nm.
2.6.4 | Cytokine secretion analysis by ELISA
After 3, 7, 14, 28, and 42 days in culture, the culture medium was col-
lected, centrifuged, and stored at −20°C until analyses were performed
(n = 3). The concentrations of BMP‐2, OSM, TNF‐α, and TGF‐β were
determined using ELISA kits according to the manufacturer's instruc-
tions. Culture medium with cell‐free scaffolds served as blanks.
2.6.5 | RNA extraction and real‐time qPCR
Gene expression was studied after 3, 7, 14, and 28 days of osteogenic
differentiation (n = 4). Briefly, scaffolds with cells were washed with
PBS and cut into small pieces before adding 1 ml of Trizol (Invitrogen,
Breda, the Netherlands). The cell extract was collected, mixed with
chloroform (Sigma‐Aldrich, St. Louis, USA), and centrifuged. Only the
upper aqueous phase was collected and mixed with equal amount of
isopropanol (Sigma‐Aldrich, St. Louis, USA). After 10 min of incubation
at room temperature, the mixture was centrifuged and washed with
75% alcohol. Thereafter, the obtained RNA pellet was dissolved in
RNase‐free water, and the RNA concentration was measured with a
spectrophotometer (NanoDrop 2000, Thermo Scientific, Wilmington,
DE, USA).
First‐strand cDNA was reverse transcribed from RNA using the
iScript™ Select cDNA Synthesis Kit (Bio‐Rad, California, USA). After-
wards, cDNA was further amplified, and the expression of specific
genes was quantified using quantitative polymerase chain reaction
(qPCR) MasterMix Plus for SYBR® Green I (Eurogentec, Seraing, Bel-
gium) and a real‐time PCR detection system (CFX96™ Real‐Time PCR
Detection system, Bio‐Rad). Osteogenic differentiation‐related marker
genes were evaluated, including ALP, bone sialoprotein (BSP), collagen
type 1 (COL1), runt‐related transcription factor 2 (RUNX2), and
osteocalcin (OCN). The sequence of applied primers is given inTable 1.
The expression levels were analysed and compared with the house-
keeping gene glyceraldehyde 3‐phosphate dehydrogenase (GAPDH).
The specificity of the primers was confirmed separately before the
real‐time PCR reaction. The expression of the tested genes was calcu-
lated using the 2−ΔΔCt method (Schmittgen & Livak, 2008) using
ADMSC group on Day 3 as the reference group.
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2.6.6 | Histological staining and
immunohistochemistry
To visualize the distribution of cells in the scaffolds, samples were col-
lected on Days 14, 28, and 42 (n = 3) and then fixed in 10%
phosphate‐buffered formalin for 24 hr and dehydrated through graded
ethanol, cleared with xylene, and embedded in paraffin. Serial sections
(thickness 5 μm) were cut using a microtome (Leica RM2165,
Nussloch, Germany) from each sample and used for haematoxylin
and eosin (HE), CD68, and Von Kossa staining.
For CD68 staining, samples were put in sodium citrate (Sigma‐
Aldrich, Zwijndrecht, the Netherlands) and heated to 70°C for
10 min in microwave oven. After rinsing in PBS, samples were preincu-
bated with 10% donkey serum (Sigma‐Aldrich, Zwijndrecht, the Neth-
erlands) for 10 min and then incubated with the primary antibody
mouse anti‐human CD68 clone KP1 (1:200; Dako, Glostrup, Denmark)
overnight at 4°C. After rinsing in PBS, samples were incubated with
the biotinylated secondary antibody donkey anti‐mouse (1:500;
Merck, Darmstadt, Germany) for 60 min and counterstained with
haematoxylin (Sigma‐Aldrich, Zwijndrecht, the Netherlands) for 10 s.
Samples were then dehydrated through a graded series of ethanol
and mounted.
For Von Kossa staining (only on Day 42), 5% silver nitrate (Sigma‐
Aldrich, Zwijndrecht, the Netherlands) was added, and samples were
placed under ultraviolet light for 30 min. After rinsing in MilliQ, 2%
sodium thiosulfate (Merck, Darmstadt, Germany) was added to
remove the unreacted silver for 5 min. Next, samples were washed
with running tap water for 10 min and counterstained with nuclear
fast red (Polysciences, Warrington, PA, USA) for 10 min. Samples
were then dehydrated through a graded series of ethanol and
mounted.
2.7 | Statistics
Data are presented as mean ± standard deviation (SD). Statistical anal-
ysis was performed by SPSS Statistics 19 software (IBM, New York,
USA). Quantitative results were analysed using one‐way analysis of
variance followed by Fisher's least significance difference test.
p values less than 0.05 were considered statistically significant.
3 | RESULTS
3.1 | Characterization of ADMSCs
ADMSCs showed positive expression for MSC surface markers CD73
(99.4 ± 0.2%), CD90 (98.0 ± 1.4%), and CD105 (86.1 ± 3.5%) and neg-
ative expression of CD45 (0.24 ± 0.0%; Figure 2a–d). Evaluation of
mineralization proved the osteogenic differentiation capacity of pri-
mary human ADMSCs with calcium content values for ADMSCs
monocultures on Days 14 and 28 of 64.6 ± 7.4 and
313.0 ± 28.0 μg/ml, respectively (data not shown).
3.2 | Characterization of M1 and M2 macrophages
Human THP‐1 monocytic cells were induced into M0 macrophages
via activation with PMA and further differentiated into M1 or M2
macrophages using LPS/IFN‐γ or IL‐4/IL‐13, respectively. Activation
with PMA changed the THP‐1 cells from cells growing in suspension
to adherent cells. Morphologically, M1 macrophages showed a more
spindle‐like shape compared with M2 macrophages (data not shown).
Cytokine secretion levels of TNF‐α and TGF‐β were measured to
analyse induction of M1 and M2 macrophages (Figure 2g). A signifi-
cantly higher TNF‐α concentration was measured for M1 macro-
phages (492.8 ± 33.6 ng/ml) compared with M2 macrophages
(3.1 ± 0.7 ng/ml; p < 0.001). In contrast, a significantly higher con-
centration of TGF‐β was determined for M2 macrophages
(647.7 ± 103.5 ng/ml) compared with M1 macrophages
(188.7 ± 43.0 ng/ml; p < 0.001).
Immunostaining for macrophage phenotypes showed a mixture of
M1 and M2 macrophages after induction (Figure 2e). Following polar-
ization into M1 macrophages, more positive staining for the M1
marker CCR7 and less positive staining for the M2 marker CD36 were
observed. In contrast, M2 polarized macrophages demonstrated
increased positive staining for CD36 and less positive staining for
CCR7. Upon fluorescence signal quantification, significant differences
between M1 and M2 macrophages were determined (Figure 2f). M1
macrophages showed a significantly higher expression of CCR7
(0.679 ± 0.127; p < 0.05) than CD36 (0.351 ± 0.178), the opposite
was observed for M2 macrophages, with CD36 (1.359 ± 0.247;
TABLE 1 Primer sequences used for real‐time quantitative polymerase chain reaction
Gene Forward (5′ → 3′) Reverse (5′ → 3′)
ALP CCCAAAGGCTTCTTCTTG CTGGTAGTTGTTGTGAGCAT
BSP AACCTACAACCCCACCACAA AGGTTCCCCGTTCTCACTTT
COL1 GGTGTAAGCGGTGGTGGTTAT GCTGGGATGTTTTCAGGTTGG
OCN GACTGTGACGAGTTGGCTGA CTGGAGAGGAGCAGAACTGG
RUNX2 GGAGTGGACGAGGCAAGAGTTT AGCTTCTGTCTGTGCCTTCTGG
GAPDH CTCTGCTCCTCCTGTTCGACA ACGACCAAATCCGTTGACTC
Note. ALP: alkaline phosphatase; BSP: bone sialoprotein; COL1: collagen type 1; GAPDH: glyceraldehyde 3‐phosphate dehydrogenase; OCN: osteocalcin;
RUNX2: runt‐related transcription factor 2.
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p < 0.001) being significantly higher expressed compared with CCR7
(0.209 ± 0.109).
3.3 | Cell seeding efficiency and DNA content
Twenty‐four hours after cell seeding, the DNA content of the adher-
ent cells for each experimental group was measured to assess the cell
seeding efficiency (Figure 3a). Similar cell seeding efficiencies of
70.4 ± 4.0%, 59.6 ± 8.6%, 63.4 ± 15.9%, and 66.0 ± 9.9% were
observed for the ADMSCs monoculture, THP1‐ADMSCs, M1‐
ADMSCs, and M2‐ADMSCs cocultures, respectively (p > 0.05).
All experimental groups showed a slight increase in DNA content
from Days 1 to 7 and then a slight decrease from Days 14 to 28
(Figure 3b). On Days 1 and 3, the DNA content of the ADMSCs mono-
culture was significantly lower compared with all other groups
(p < 0.01). On Days 7 and 14, the DNA content of the monoculture
was significantly lower compared with the M2‐ADMSCs coculture
(p < 0.05). On Day 28, the DNA content of the ADMSCs monoculture
was significantly lower compared with all other groups (p < 0.01). At
each time point, similar DNA content values were measured for all
coculture groups (p > 0.05).
3.4 | ALP activity
ADMSCs monoculture and M1‐ADMSCs and M2‐ADMSCs cocul-
tures showed a similar trend for ALP activity over the culture period,
that is, a rise during the early stage and a decline in the later stage
(Figure 3c). On both Days 14 and 28, the gross ALP activity for
ADMSCs was significantly higher compared with all other experimen-
tal groups (p < 0.001). For the THP1‐ADMSCs coculture, a lower
gross ALP activity was observed throughout the entire culture. On
both Days 7 and 14, the gross ALP activity for the THP1‐ADMSCs
coculture was significantly lower compared with all other coculture
groups (p < 0.001).
FIGURE 2 Characterization of adipose‐derived mesenchymal stromal cells (ADMSCs), M1, and M2 macrophages. (a–d) The ratio of positive cells
in ADMSCs was compared with the ratio in negative controls. Gates were set using the negative control. Red lines indicate the histogram for
ADMSCs markers, and green lines indicate the histogram for negative controls. (e) M1 macrophages and M2 macrophages were stained with M1
marker CCR7 (red), M2marker CD36 (green), and 4′,6‐diamidino‐2‐phenylindole (DAPI) (blue). (f) Quantification of relative fluorescence intensity
of CCR7 and CD36 in M1 macrophages and M2 macrophages. (g) The concentration of tumour necrosis factor alpha (TNF‐α) and transforming
growth factor β (TGF‐β) in M1 and M2 macrophage culture medium was measured by ELISA. Scale bar, 50 μm. “*” indicates significant difference
between groups. *p < 0.05, **p < 0.01, ***p < 0.001 [Colour figure can be viewed at wileyonlinelibrary.com]
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3.5 | Mineralization
Mineralization levels for all experimental groups were relatively low on
Days 14 and 28, without significant differences among groups
(p > 0.05; Figure 3d). On Day 42, the calcium content for the ADMSCs
monoculture was significantly higher compared with all other groups
(p < 0.001).
3.6 | Cytokine secretion analysis by ELISA
After correction by blank values, TGF‐β concentrations showed nega-
tive values at all time points. On Day 14, the TGF‐β concentration of
coculture groups was significantly lower compared with the ADMSCs
monoculture (p < 0.05; Figure 4a).
TNF‐α concentration remained at a low level at all time points. On
Day 3, TNF‐α concentration of the M2‐ADMSCs coculture was higher
compared with the ADMSCs monoculture and the THP1‐ADMSCs
coculture (p < 0.05; Figure 4b). On Day 7, the TNF‐α concentration
of the M2‐ADMSCs coculture was higher compared with the THP1‐
ADMSCs coculture (p < 0.01; Figure 4b).
OSM concentration showed an apparent trend of increasing at an
early stage and decreasing at a late stage during culture for all
experimental groups. On Days 14 and 42, OSM concentration of the
ADMSCs monoculture was higher compared with all coculture groups
(p < 0.001; Figure 4c).
The BMP‐2 concentration decreased with culture time. The BMP‐2
concentration of the ADMSCs monoculture was higher compared
with all coculture groups at all time points (p < 0.05; Figure 4d).
3.7 | Real‐time qPCR
Osteogenic differentiation of ADMSCs was inhibited upon coculture
with monocytes or macrophage subtypes along with the decrease in
the expression of osteogenesis‐related genes, which was examined
by real‐time PCR analysis (Figure 5). For ALP gene expression, no
significant differences among the experimental groups at Day 3 were
observed (Figure 5a). Significantly, higher ALP gene expression was
observed for the ADMSCs monoculture compared with the three
coculture groups at Days 7 (p < 0.001), 14 (p < 0.05), and 28
(p < 0.01). For BSP gene expression, significantly higher expression
was observed for the ADMSCs monoculture compared with the
three coculture groups at Days 3 (p < 0.01), 7 (p < 0.05), 14
(p < 0.01), and 28 (p < 0.001; Figure 5b). No significant differences
between ADMSC and the coculture groups were observed for
FIGURE 3 (a) Cell seeding efficiency in each group. (b) DNA content in each group on Days 1, 3, 7, 14, and 28. (c) Gross alkaline phosphatase
(ALP) activity in each group on Days 3, 7, 14, and 28. (d) Calcium content in each group on Days 14, 28, and 42. “*” indicates significant difference
compared with the adipose‐derived mesenchymal stromal cell (ADMSC) group at the same time point. *p < 0.05, **p < 0.01, ***p < 0.001
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COL1 gene expression at any time point (Figure 5c). For OCN gene
expression, significantly higher expression was observed for the
THP1‐ADMSCs coculture compared with the ADMSCs monoculture
at Days 14 (p < 0.001) and 28 (p < 0.05; Figure 5d). Significantly
higher expression was observed for THP1‐ADMSCs coculture com-
pared with M1‐ADMSCs and M2‐ADMSCs cocultures at Days 14
and 28 (p < 0.05). For RUNX2 gene expression, significantly higher
expression was observed for the ADMSCs monoculture compared
with the M2‐ADMSCs coculture at each time point (p < 0.01; Figure
5e). Significantly higher expression was observed for ADMSCs
monoculture compared with the THP1‐ADMSCs and M1‐ADMSCs
cocultures at Days 7 (p < 0.01), 14 (p < 0.05), and 28 (p < 0.05).
3.8 | Histological staining and
immunohistochemistry
HE‐stained histological sections of all experimental groups are pre-
sented in Figure S1. For all experimental groups, the distribution of
cells in the scaffolds was not homogeneous. At Day 14, most cells
were distributed on the surface of the scaffolds, and only a small num-
ber of cells were observed in the centre of the scaffolds. From Day 14
to Days 28 and 42, increasingly more cells were observed infiltrating
the scaffolds. A large number of cells mounted layer upon layer on
the surface of the scaffolds, especially for the THP1‐ADMSCs, M1‐
ADMSCs, and M2‐ADMSCs coculture groups.
The pan‐macrophage marker CD68 was used to monitor the distri-
bution of monocytes/macrophages within coculture groups (Figure
S2). No CD68‐positive staining was observed for the ADMSCs mono-
culture. In the coculture groups, CD68‐positive stained cells were
mostly distributed on the superficial zone of the scaffolds. From Days
14 to 42, more and more monocytes/macrophages were observed
infiltrating the scaffolds. No apparent differences in the distribution
of CD68‐positive stained cells in all three coculture groups were
observed.
Von Kossa staining was used to monitor mineral deposition (specif-
ically PO4
3−) within the scaffolds (Figure S3). No mineral deposition
was observed for coculture groups over the entire culture period.
However, the ADMSCs monoculture showed superficial mineraliza-
tion on Day 42.
FIGURE 4 Cytokine secretion analysis by ELISA. (a) Corrected transforming growth factor β (TGF‐β) concentration in each group on Days 3, 7,
14, 28, and 42. (b) Corrected tumour necrosis factor alpha (TNF‐α) concentration in each group on Days 3, 7, 14, 28, and 42. (c) Corrected
oncostatin M (OSM) concentration in each group on Days 3, 7, 14, 28, and 42. (d) Corrected bone morphogenetic protein 2 (BMP‐2) concentration
in each group on Days 3, 7, 14, 28, and 42. “*” indicates significant difference compared with the adipose‐derived mesenchymal stromal cell
(ADMSC) group at the same time point. *p < 0.05, **p < 0.01, ***p < 0.001
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4 | DISCUSSION
In view of the eminent role of monocytes and macrophages in the
inflammatory cascade that initiates wound healing and tissue regener-
ation (Soltan, Rohrer, & Prasad, 2012), the objective of this study was
to evaluate the effect of monocytes and macrophage subtypes on
osteogenic differentiation of ADMSCs. Here, we used 3D PLGA/PCL
scaffolds and a direct coculture model to culture primary human
ADMSCs with THP1 monocytes, M1 macrophages, or M2 macro-
phages in osteogenic medium with a monoculture of ADMSCs serving
as control. Our findings indicate that the osteogenic differentiation of
ADMSCs is inhibited by monocytes and different macrophage sub-
types in 3D scaffolds. Whereas low mineralization was observed for
any of the cocultures, ADMSCs monoculture showed significantly
higher mineralization after 42 days of culture. Further, cocultured
ADMSCs with monocytes/macrophages showed a downregulation of
the expression of osteogenic markers (e.g., ALP, BSP, and RUNX2)
compared with ADMSCs monocultures, which are speculated to be
related to OSM and BMP‐2 secretion of ADMSCs.
Regarding interaction between MSCs and monocytes/
macrophages, several previous studies cocultured macrophages with
MSCs and reported diverse effects (i.e., stimulatory or inhibitory) on
the osteogenic differentiation of MSCs (C. Chen et al., 2012; Z. Chen
et al., 2014; Fernandes et al., 2013; Guihard et al., 2012). This varia-
tion can be attributed to multiple factors, including the source of stem
cells, utilized polarization protocols for macrophages, and cell ratios.
Therefore, the exact role of monocytes/macrophages on osteogenic
differentiation of MSCs requires a more comprehensive and more
accurate research set‐up. Our group has developed a delicate, indirect
2D coculture system using transwells and theTHP‐1 cell line as mono-
cyte source and showed that different types of macrophages differen-
tially affected the behaviour of cocultured ADMSCs (Zhang et al.,
2017). To be more specific, M2 macrophages, rather than M1 macro-
phages, promoted the mineralization of ADMSCs and proved that this
is mediated through paracrine signalling pathways. However, given the
cell behavioural difference in 3D and 2D culture systems and the fact
that 3D scaffolds are a crucial part of cell‐based bone constructs, we
here established a direct 3D coculture system by using human primary
ADMSCs, THP‐1 cells and electrospun scaffolds. In contrast to the
previously observed stimulatory effects of macrophages on the
osteogenic differentiation of ADMSCs (Zhang et al., 2017), mono-
cytes, M1 macrophages, and M2 macrophages significantly inhibited
the osteogenic differentiation of cocultured ADMSCs. This is evi-
denced by decreased ALP activity, mineralization content, and
FIGURE 5 Gene expression of osteogenic markers. (a) Gene expression of alkaline phosphatase (ALP) in each group on Days 3, 7, 14, and 28. (b)
Gene expression of bone sialoprotein (BSP) in each group on Days 3, 7, 14, and 28. (c) Gene expression of collagen type 1 (COL1) in each group on
Days 3, 7, 14, and 28. (d) Gene expression of osteocalcin (OCN) in each group on Days 3, 7, 14, and 28. (e) Gene expression of runt‐related
transcription factor 2 (RUNX2) in each group on Days 3, 7, 14, and 28. “*” indicates significant difference compared with the adipose‐derived
mesenchymal stromal cell (ADMSC) group at the same time point. *p < 0.05, **p < 0.01, ***p < 0.001. “#” indicates significant difference compared
with Day 3 in the same group. #p < 0.05, ##p < 0.01, ###p < 0.001. “+” indicates significant difference compared with Day 7 in the same group.
+p < 0.05, ++p < 0.01, +++p < 0.001. “$” indicates significant difference compared with Day 14 in the same group. $p < 0.05, $$p < 0.01,
$$$p < 0.001
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expression of several osteogenic markers. These results further vali-
dated previous reports that cell–cell interactions are different in 2D
and 3D culture models (D. Y. Chen et al., 2013; Valles et al., 2015).
With regard to the mechanism behind this inhibitory effect of
monocytes and macrophages, pro‐inflammatory and anti‐inflammatory
cytokines were measured during the culture time, but no significant
differences in inflammatory cytokine concentrations in the coculture
medium were detected. However, a significantly decreased OSM and
BMP‐2 secretion was found in cocultures compared with the mono-
culture. This indicated that monocytes/macrophages inhibited certain
osteogenic signalling pathways in our 3D coculture system. The
observed inhibitory effect may come from other cytokines than
inflammatory cytokines such as TNF‐α and TGF‐β secreted by
monocytes/macrophages (C. Chen et al., 2012) or the direct interac-
tion between monocytes/macrophages, scaffold, and ADMSCs.
The other main difference of this 3D coculture compared with our
previous 2D coculture model is the usage of PL instead of FBS as
serum supplement for the sake of optimizing for potential clinical
application. A rapidly increasing number of studies use PL, rather than
FBS, as nutritional supplement in cell culture media for human cell cul-
ture (Astori et al., 2016; Burnouf, Strunk, Koh, & Schallmoser, 2016;
Ruggiu, Ulivi, Sanguineti, Cancedda, & Descalzi, 2013). Except for
the beneficial effects on the mineralization of ADMSCs, platelet deriv-
atives were also shown to exert an anti‐inflammatory effect on
monocytes/macrophages (Linke et al., 2017; Papait, Cancedda,
Mastrogiacomo, & Poggi, 2018; Renn, Kao, Wang, & Burnouf, 2015).
Furthermore, PL contains a high concentration of TGF‐β as reported
previously, with fluctuations from 900 to 15,000 pg/ml (Fekete et al.,
2012; Renn et al., 2015; Salvade et al., 2010). In our research, the con-
centration of TGF‐β in blank controls (i.e., culture medium incubated
with scaffold only) was 2,426.6 ± 185.9 pg/ml (data not shown). These
high values led to negative values after correction for blank controls.
This observation suggests that the cells consume a large amount of
TGF‐β in the process of proliferation and differentiation. Alternatively,
the low concentrations of TNF‐α might imply the transition of M1
macrophages into M2 macrophages after 3 days of coculture with
ADMSCs (Yin, Pang, Bai, Zhang, & Geng, 2016), which is a contradic-
tory finding to an earlier publication suggesting that PL‐treated MSCs
support the maintenance of macrophages in a pro‐inflammatory con-
dition (Ulivi, Tasso, Cancedda, & Descalzi, 2014). However, the possi-
ble transition towards M2 macrophages might also explain the
similarities regarding the osteogenic differentiation of ADMSCs upon
coculture with either M1 or M2 macrophages in this study.
Macrophage differentiation and polarization are highly dynamic. In
response to micro‐environmental cues, macrophages can rapidly
switch from one phenotype to the other during the culture period
(den Breems & Eftimie, 2016; Wang, Liang, & Zen, 2014). Generally,
CCR7, HLA‐DR, CD163, and CD206 are used as markers for M1 or
M2 macrophages. Nevertheless, none of these are fully discriminative
for a particular subtype of macrophages (Spiller et al., 2014). Under
these circumstances, we chose CD68 as a pan‐macrophage marker
to assess the distribution of seeded monocytes or macrophages within
coculture scaffolds. Combined with the results of HE, CD68, and Von
Kossa staining, the two types of cells were uniformly distributed in the
scaffolds. Most of the cells were distributed in a superficial layer of the
scaffolds. Cells were mounted layer upon layer on the surface of the
scaffolds. During the culture, ECM was deposited on the surface of
the scaffolds forming a biofilm‐like structure. The migration of cells
from the scaffold surface to the scaffold interior was likely hindered
by this biofilm, which acted as a barrier (Lyons et al., 2010). This phe-
nomenon might explain the low calcium content values and positive
Von Kossa staining only at the surface of the scaffolds.
Molecular analysis of osteogenic markers showed that coculturing
ADMSCs with monocytes or macrophages affect cytokine secretion
(e.g., OSM and BMP‐2) and osteogenic gene expression (e.g., ALP,
BSP, RUNX2, and OCN) of ADMSCs. Monocytes, M1 macrophages,
and M2 macrophages significantly inhibited the osteogenic differenti-
ation of cocultured ADMSCs in the early and late stages of osteogen-
esis, evidenced by lower ALP activity and BMP‐2 concentrations and
lower gene expression of the early‐stage osteogenic marker ALP on
Days 7 and 14 and late‐stage osteogenic marker BSP on Day 28.
According to the comparison between coculture groups, monocytes
played a stronger inhibiting role on ALP gene expression compared
with M1 and M2 macrophages. Moreover, protein levels measured
by ELISA showed that monocytes, M1 macrophages, and M2 macro-
phages significantly inhibited the secretion of OSM and BMP‐2 com-
pared with ADMSCs monoculture. An interesting finding was the
significantly increased OCN gene expression on Days 14 and 28 for
the THP1‐ADMSCs coculture compared with all other experimental
groups.
There are also several limitations to our study. First, to address
multivariate research questions that require large numbers of cells
and for reproducibility of results, the THP‐1 cell line rather than
primary human monocytes and macrophages was used. Although
THP‐1 cells have been reported to retain all necessary markers and
morphologic features of primary monocytes (Auwerx, 1991; Qin,
2012), further studies using macrophages derived from primary mono-
cytes of different donors are desired. Second, due to the lack of exclu-
sive markers for M1 and M2 macrophages, we cannot dynamically
monitor the macrophage behaviour during the culture time. A delicate
staining method to follow the fate of macrophages and ADMSCs and
to explore the cell–cell interaction would greatly aid in elucidating the
mechanism of the observed inhibitory effects of monocytes/
macrophages in vitro.
In conclusion, this study used cocultures of monocytes/
macrophages and ADMSCs on 3D PLGA/PCL scaffolds to evaluate
effects of cell–cell interactions on the osteogenic differentiation of
ADMSCs. We found that monocytes and macrophage subtypes
inhibit the osteogenic differentiation of ADMSCs on 3D PLGA/PCL
scaffolds. Cocultured monocytes/macrophages decreased the expres-
sion of osteogenic markers ALP, BSP, and RUNX2. These data high-
light the ignored fact that inflammation may regulate osteoblast
activity of MSC‐based bone constructs within the bone micro‐
environment. It implies that strict control of inflammation may be
necessary to create an anabolic environment that improves the per-
formance of cell‐based bone constructs. Additionally, compared with
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macrophage subtypes, monocytes played a stronger inhibiting role on
the osteogenic differentiation of ADMSCs. Therefore, it seems that
the transient activation of monocytes after fracture injury is impor-
tant for fracture repair.
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SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of the article.
Figure S1. HE‐staining of paraffin sections for each experimental
group after 14, 28 and 42 days of culture. Most cells (shown by arrows
head) were distributed on the surface of the scaffolds at day 14. More
cells were observed entering the scaffolds from day 14 to day 42. A
large number of cells mounted layer upon layer on the surface of the
scaffolds. “*” indicates scaffolds. Scale bar, 50μm.
Figure S2. CD68 staining of different group of PLGA/PCL scaffolds
after 14, 28 and 42 days of culture. CD68‐positive cells stained in
brown (shown by arrows head). No CD68‐positive staining was
observed for the ADMSCs mono‐culture. “*” indicates scaffolds. Scale
bar, 50μm.
Figure S3. Von Kossa staining of different group of PLGA/PCL scaf-
folds after 42 days of culture. Von Kossa staining was used to monitor
mineral deposition (specifically PO4
3‐) within the scaffolds. Mineral
deposition stained in black (shown by arrows head). ADMSCs mono‐
culture showed superficial mineralization at day 42. “*” indicates scaf-
folds. Scale bar, 100μm.
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